CoChat

Comparative Efficacy of Echinocandins and Nonechinocandins for the Treatment of Candida parapsilosis Infections: AMeta‐analysis

Kale‐Pradhan, Pramodini B., Morgan, Geoffrey, Wilhelm, Sheila M., Johnson, Leonard B. · 2010 · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Cited by 37

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Study Objective. To compare the efficacy of echinocandins and nonechinocandins in the treatment of candidemia or invasive candidiasis due to Candida parapsilosis. Design. Meta‐analysis of five randomized, blinded, comparative trials. Patients. A total of 1169 patients (mean age 55.5 yrs, 57.8% male) with invasive candidiasis or candidemia treated with an echinocandin or other antifungal agents. Measurements and Main Results. The PubMed, MEDLINE, Toxnet, and Cochrane Central Register of Controlled Trials databases were searched for relevant English‐language articles to identify appropriate randomized trials. The quality of studies was assessed with the Jadad scoring system. Data on number of patients, age, and treatment success rate were extracted by two investigators independently into a standardized data collection form. Overall C. parapsilosis treatment success rates with echinocandins were compared with nonechinocandins. Jadad scores of the five studies that met all of the selection criteria ranged from 2–5 (out of 5), with a median of 4. Among the 1169 patients with invasive candidiasis or candidemia, 202 (17.3%) had C. parapsilosis. Among these C. parapsilosis cases, 102 received an echinocandin and 100 received a comparator drug. The success rates of treating C. parapsilosis were similar for the echinocandin group versus other antifungal treatment groups (76.5% [78/102] vs 73% [73/100]). A fixed‐effects model was applied secondary to a low level of heterogeneity among the studies (I 2=0%). The combined risk ratio demonstrated that echinocandins are not significantly different from other antifungal agents for the treatment of candidemia or invasive candidiasis due to C. parapsilosis (risk ratio 1.03, 95% confidence interval 0.88–1.21). Conclusion. Echinocandins are as effective as comparator drugs for the treatment of candidemia or invasive candidiasis due to C. parapsilosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1592/phco.30.12.1207

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 37

Metadata

Authors
Kale‐Pradhan, P. B., Morgan, G., Wilhelm, S. M., & Johnson, L. B.
Venue
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Publisher
Wiley
Published
2010-12
Volume
30
Issue
12
Pages
1207-1213
ISSN
  • 0277-0008 (ISSN-L)
  • 1875-9114
OpenAlex
W2021907711
Cited by
37
References
9
FWCI
2.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative Efficacy of Echinocandins and Nonechinocandins for the Treatment of Candida parapsilosis Infections: AMeta‐analysis. https://app.cochat.ai/papers/10.1592/phco.30.12.1207
The paper
Kale‐Pradhan, P. B., Morgan, G., Wilhelm, S. M., & Johnson, L. B. (2010). Comparative Efficacy of Echinocandins and Nonechinocandins for the Treatment of Candida parapsilosis Infections: AMeta‐analysis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1592/phco.30.12.1207

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.